All In Biotech

Drug Trial Radar · NCT04728516

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

The Effect of Vonoprazan-based Dual Eradication Therapy vs PPI Treatment on Gastrointestinal Bleeding in ACS Patients With Hp Infection and Coronary Stents: an Open-label, Randomized, Controlled Trial

Last checked: Nov 19, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,600

Planned (sponsor's estimate)

Start

Apr 12, 2023

Primary completion

Jun 30, 2026

Study completion Jun 30, 2026

Sponsor

Lead sponsor
Qilu Hospital of Shandong UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 28, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with acute coronary syndrome (ACS) after Percutaneous Coronary Intervention (PCI) require routine treatment with dual antiplatelet (DAPT) treatment, but with the high risk of bleeding, gastrointestinal bleeding is the most common type of major bleeding. Helicobacter pylori (Hp) infection is a high-risk factor for gastrointestinal bleeding, with an incidence of about 50%. Foreign authoritative DAPT guidelines do not give individual guidance to Hp-infected patients. It is recommended that those with high bleeding risk should be combined with proton pump inhibitors (PPI), but long-term compliance with PPI is not ideal. Authoritative experts in China have agreed to recommend Hp detection and eradication therapy for DAPT patients, but loss of evidence. Vonoprazan is a novel potassium ion competitive acid blocker, based on Vonoprazan's dual Hp eradication therapy is simple and effective. Our team will conduct a multi-center, open-label, randomized controlled clinical trial using a non-inferior design to compare the combination of Vonoprazan + amoxicillin combined with pantoprazole (PPI) for 6 months after PCI on the bleeding events of the digestive tract.

Conditions

  • Acute Coronary Syndrome
  • Helicobacter Pylori Infection

Interventions

  • Vonoprazan-based dual eradication therapy for two weeksDrug

    Patients with ACS after PCI, associated with positive Hp need a long-term DAPT treatment. We conducted a study on the prevention of gastrointestinal bleeding between vonoprazan-based dual eradication therapy for two weeks and pantoprazole for six months of a rountine therapy.

  • amoxicillinDrug

    amoxicillin

  • PantoprazoleDrug

    Pantoprazole

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Gastrointestinal bleeding of 6 months in patients with ACS after PCITime frame: 6 months

Locations

42 sites in 1 country. Site status is shown where the registry gives one.

  • Bozhou People's Hospital

    Bozhou, Anhui, China · Recruiting

  • Chuzhou First People's Hospital

    Chuzhou, Anhui, China · Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • Aviation General Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First People'S Hospital of Zunyi

    Zunyi, Guizhou, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • The First Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China · Recruiting

  • Qinghai Red Cross Hospital

    Xining, Qinghai, China · Recruiting

  • Qilu Hospital of Shandong University Dezhou Hospital

    Dezhou, Shandong, China · Recruiting

  • Pingyuan First People'S Hospital

    Dezhou, Shandong, China · Recruiting

  • NINGJIN People's Hospital

    Dezhou, Shandong, China · Recruiting

  • Dongying People's Hospital

    Dongying, Shandong, China · Recruiting

  • THE Second People's Hospital of Dongying

    Dongying, Shandong, China · Recruiting

  • Heze Municipal Hospital

    Heze, Shandong, China · Recruiting

  • The 960th Hospital of the Joint Logistic Support Force

    Jinan, Shandong, China · Withdrawn

  • Shandong Second Provincial General Hospital

    Jinan, Shandong, China · Withdrawn

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    Jinan, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Shandong Provincial Third Hospital

    Jinan, Shandong, China · Recruiting

  • The fourth People's Hospital of jinan

    Jinan, Shandong, China · Recruiting

  • Shandong Public Health Clinical Center

    Jinan, Shandong, China · Recruiting

  • JINA CITY People's Hospital

    Jinan, Shandong, China · Recruiting

  • Central Hospital Affiliated to Shandong First medical University

    Jinan, Shandong, China · Withdrawn

  • The First People's Hospital of Jining City

    Jining, Shandong, China · Not yet recruiting

  • Liaocheng People's Hospital

    Liaocheng, Shandong, China · Not yet recruiting

  • Linyi City People's Hospital

    Linyi, Shandong, China · Not yet recruiting

  • Linshu County People'S Hospital

    Linyi, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University (Qingdao)

    Qingdao, Shandong, China · Not yet recruiting

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China · Recruiting

  • Affiliated Hospital of Shandong Second Medical University

    Weifang, Shandong, China · Recruiting

  • Weifang Hospital of Traditional Chinese Medicine

    Weifang, Shandong, China · Recruiting

  • Weihai Central Hospital

    Weihai, Shandong, China · Withdrawn

  • Weihai Municipal Hospital

    Weihai, Shandong, China · Not yet recruiting

  • Haiyang People's Hospital

    Yantai, Shandong, China · Recruiting

  • Shandong Healthcare Group Zaozhuang Central Hospital

    Zaozhuang, Shandong, China · Withdrawn

  • Zaozhuang Municipal Hospital

    Zaozhuang, Shandong, China · Recruiting

  • Zibo Central Hospital

    Zibo, Shandong, China · Withdrawn

  • The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Hospital of Chengdu University of Traditional Chinese Medicine

    Chengdu, Sichuan, China · Withdrawn

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.